The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Neuropathy Pain Treatment Market Research Report 2025
Synopsis
This report studies the Neuropathy Pain Treatment market,
Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathy Pain Treatment is used for Neuropathic pain.
The global Neuropathy Pain Treatment market was valued at US$ 8527 million in 2023 and is anticipated to reach US$ 10730 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
Global Neuropathy Pain Treatment key players include Eli Lilly, Pfizer, etc. Global top two manufacturers hold a share over 65%.
North America is the largest market, with a share about 45%, followed by Asia-Pacific and Europe, both have a share about 50 percent.
In terms of product, Calcium channel alpha 2-delta ligands is the largest segment, with a share about 70%. And in terms of application, the largest application is Retail Pharmacies, followed by Hospitals, etc.
This report aims to provide a comprehensive presentation of the global market for Neuropathy Pain Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuropathy Pain Treatment.
Report Scope
The Neuropathy Pain Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neuropathy Pain Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neuropathy Pain Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Depomed
Eli Lilly
Endo
Grünenthal Group
Arbor Pharmaceuticals
Segment by Type
Calcium Channel Alpha 2-delta Ligands
Serotonin-norepinephrine Reuptake Inhibitors
Others
Segment by Application
Retail Pharmacies
Hospitals
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neuropathy Pain Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
This report studies the Neuropathy Pain Treatment market,
Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathy Pain Treatment is used for Neuropathic pain.
The global Neuropathy Pain Treatment market was valued at US$ 8527 million in 2023 and is anticipated to reach US$ 10730 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
Global Neuropathy Pain Treatment key players include Eli Lilly, Pfizer, etc. Global top two manufacturers hold a share over 65%.
North America is the largest market, with a share about 45%, followed by Asia-Pacific and Europe, both have a share about 50 percent.
In terms of product, Calcium channel alpha 2-delta ligands is the largest segment, with a share about 70%. And in terms of application, the largest application is Retail Pharmacies, followed by Hospitals, etc.
This report aims to provide a comprehensive presentation of the global market for Neuropathy Pain Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuropathy Pain Treatment.
Report Scope
The Neuropathy Pain Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neuropathy Pain Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neuropathy Pain Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Depomed
Eli Lilly
Endo
Grünenthal Group
Arbor Pharmaceuticals
Segment by Type
Calcium Channel Alpha 2-delta Ligands
Serotonin-norepinephrine Reuptake Inhibitors
Others
Segment by Application
Retail Pharmacies
Hospitals
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neuropathy Pain Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuropathy Pain Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Calcium Channel Alpha 2-delta Ligands
1.2.3 Serotonin-norepinephrine Reuptake Inhibitors
1.2.4 Others
1.3 Market by Application
1.3.1 Global Neuropathy Pain Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Retail Pharmacies
1.3.3 Hospitals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neuropathy Pain Treatment Market Perspective (2019-2030)
2.2 Neuropathy Pain Treatment Growth Trends by Region
2.2.1 Global Neuropathy Pain Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Neuropathy Pain Treatment Historic Market Size by Region (2019-2024)
2.2.3 Neuropathy Pain Treatment Forecasted Market Size by Region (2025-2030)
2.3 Neuropathy Pain Treatment Market Dynamics
2.3.1 Neuropathy Pain Treatment Industry Trends
2.3.2 Neuropathy Pain Treatment Market Drivers
2.3.3 Neuropathy Pain Treatment Market Challenges
2.3.4 Neuropathy Pain Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuropathy Pain Treatment Players by Revenue
3.1.1 Global Top Neuropathy Pain Treatment Players by Revenue (2019-2024)
3.1.2 Global Neuropathy Pain Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Neuropathy Pain Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neuropathy Pain Treatment Revenue
3.4 Global Neuropathy Pain Treatment Market Concentration Ratio
3.4.1 Global Neuropathy Pain Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuropathy Pain Treatment Revenue in 2023
3.5 Neuropathy Pain Treatment Key Players Head office and Area Served
3.6 Key Players Neuropathy Pain Treatment Product Solution and Service
3.7 Date of Enter into Neuropathy Pain Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuropathy Pain Treatment Breakdown Data by Type
4.1 Global Neuropathy Pain Treatment Historic Market Size by Type (2019-2024)
4.2 Global Neuropathy Pain Treatment Forecasted Market Size by Type (2025-2030)
5 Neuropathy Pain Treatment Breakdown Data by Application
5.1 Global Neuropathy Pain Treatment Historic Market Size by Application (2019-2024)
5.2 Global Neuropathy Pain Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Neuropathy Pain Treatment Market Size (2019-2030)
6.2 North America Neuropathy Pain Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Neuropathy Pain Treatment Market Size by Country (2019-2024)
6.4 North America Neuropathy Pain Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neuropathy Pain Treatment Market Size (2019-2030)
7.2 Europe Neuropathy Pain Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Neuropathy Pain Treatment Market Size by Country (2019-2024)
7.4 Europe Neuropathy Pain Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neuropathy Pain Treatment Market Size (2019-2030)
8.2 Asia-Pacific Neuropathy Pain Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Neuropathy Pain Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Neuropathy Pain Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neuropathy Pain Treatment Market Size (2019-2030)
9.2 Latin America Neuropathy Pain Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Neuropathy Pain Treatment Market Size by Country (2019-2024)
9.4 Latin America Neuropathy Pain Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuropathy Pain Treatment Market Size (2019-2030)
10.2 Middle East & Africa Neuropathy Pain Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Neuropathy Pain Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Neuropathy Pain Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Neuropathy Pain Treatment Introduction
11.1.4 Pfizer Revenue in Neuropathy Pain Treatment Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Depomed
11.2.1 Depomed Company Detail
11.2.2 Depomed Business Overview
11.2.3 Depomed Neuropathy Pain Treatment Introduction
11.2.4 Depomed Revenue in Neuropathy Pain Treatment Business (2019-2024)
11.2.5 Depomed Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Neuropathy Pain Treatment Introduction
11.3.4 Eli Lilly Revenue in Neuropathy Pain Treatment Business (2019-2024)
11.3.5 Eli Lilly Recent Development
11.4 Endo
11.4.1 Endo Company Detail
11.4.2 Endo Business Overview
11.4.3 Endo Neuropathy Pain Treatment Introduction
11.4.4 Endo Revenue in Neuropathy Pain Treatment Business (2019-2024)
11.4.5 Endo Recent Development
11.5 Grünenthal Group
11.5.1 Grünenthal Group Company Detail
11.5.2 Grünenthal Group Business Overview
11.5.3 Grünenthal Group Neuropathy Pain Treatment Introduction
11.5.4 Grünenthal Group Revenue in Neuropathy Pain Treatment Business (2019-2024)
11.5.5 Grünenthal Group Recent Development
11.6 Arbor Pharmaceuticals
11.6.1 Arbor Pharmaceuticals Company Detail
11.6.2 Arbor Pharmaceuticals Business Overview
11.6.3 Arbor Pharmaceuticals Neuropathy Pain Treatment Introduction
11.6.4 Arbor Pharmaceuticals Revenue in Neuropathy Pain Treatment Business (2019-2024)
11.6.5 Arbor Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
